A Single-arm Phase 2 Prospective Clinical Study of Enatumab in the Treatment of Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

NCT07190261 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
3
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Bing Han